Seelos Therapeutics Inc (SEELQ)
0.27
+0.07
(+35.00%)
USD |
OTCM |
Dec 24, 16:00
Seelos Therapeutics Free Cash Flow: -13.27M for June 30, 2024
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Cassava Sciences Inc | -78.07M |
| Bristol-Myers Squibb Co | 13.80B |
| enVVeno Medical Corp | -16.74M |
| NovaBay Pharmaceuticals Inc | -4.812M |
| Palatin Technologies Inc | -32.57M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -0.972M |
| Cash from Financing (Quarterly) | 0.742M |
| Free Cash Flow Per Share (Quarterly) | -6.183 |
| Free Cash Flow Yield | -55.93K% |